BCM
IBB icon

BTR Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

BTR Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.04M Sell
8,880
-35
-0.4% -$4.35K 0.16% 74
2022
Q2 		$1.05M Sell
8,915
-385
-4% -$45.7K 0.15% 75
2022
Q1 		$1.21M Sell
9,300
-275
-3% -$35.8K 0.15% 76
2021
Q4 		$1.46M Buy
9,575
+240
+3% +$37.2K 0.16% 72
2021
Q3 		$1.51M Hold
9,335
– – 0.19% 68
2021
Q2 		$1.53M Hold
9,335
– – 0.19% 68
2021
Q1 		$1.41M Sell
9,335
-20
-0.2% -$3.18K 0.2% 72
2020
Q4 		$1.42M Buy
9,355
+75
+0.8% +$10.7K 0.22% 67
2020
Q3 		$1.26M Sell
9,280
-300
-3% -$40.7K 0.22% 66
2020
Q2 		$1.31M Sell
9,580
-2,755
-22% -$351K 0.25% 63
2020
Q1 		$1.33M Sell
12,335
-2,385
-16% -$275K 0.29% 59
2019
Q4 		$1.77M Buy
14,720
+45
+0.3% +$5.02K 0.31% 59
2019
Q3 		$1.46M Sell
14,675
-108
-0.7% -$11.3K 0.27% 67
2019
Q2 		$1.61M Sell
14,783
-750
-5% -$79.8K 0.3% 65
2019
Q1 		$1.74M Sell
15,533
-625
-4% -$68.6K 0.33% 61
2018
Q4 		$1.56M Sell
16,158
-310
-2% -$32.9K 0.33% 63
2018
Q3 		$2.01M Sell
16,468
-45
-0.3% -$5.3K 0.35% 55
2018
Q2 		$1.81M Sell
16,513
-865
-5% -$92.5K 0.35% 56
2018
Q1 		$1.85M Buy
17,378
+924
+6% +$102K 0.37% 55
2017
Q4 		$1.76M Buy
16,454
+470
+3% +$50.2K 0.34% 56
2017
Q3 		$1.78M Sell
15,984
-210
-1% -$22.4K 0.36% 56
2017
Q2 		$1.67M Sell
16,194
-510
-3% -$50.2K 0.34% 58
2017
Q1 		$1.63M Buy
16,704
+5,949
+55% +$570K 0.34% 58
2016
Q4 		$1.04M Hold
10,755
– – 0.23% 69
2016
Q3 		$1.04M Sell
10,755
-105
-1% -$9.99K 0.23% 69
2016
Q2 		$932K Sell
10,860
-480
-4% -$43.1K 0.21% 76
2016
Q1 		$986K Sell
11,340
-600
-5% -$53.7K 0.23% 77
2015
Q4 		$1.35M Sell
11,940
-120
-1% -$13K 0.31% 74
2015
Q3 		$1.22M Sell
12,060
-2,070
-15% -$248K 0.29% 75
2015
Q2 		$1.74M Sell
14,130
-1,620
-10% -$194K 0.41% 62
2015
Q1 		$1.8M Sell
15,750
-7,665
-33% -$845K 0.44% 60
2014
Q4 		$2.37M Sell
23,415
-1,695
-7% -$165K 0.65% 54
2014
Q3 		$2.29M Buy
25,110
+1,185
+5% +$104K 0.63% 53
2014
Q2 		$2.05M Buy
23,925
+3,195
+15% +$252K 0.56% 55
2014
Q1 		$1.63M Sell
20,730
-4,965
-19% -$414K 0.48% 55
2013
Q4 		$1.95M Sell
25,695
-690
-3% -$49K 0.55% 54
2013
Q3 		$1.84M Sell
26,385
-150
-0.6% -$9.83K 0.58% 52
2013
Q2 		$1.54M Buy
+26,535
New +$1.53M 0.48% 57

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

BTR Capital Management's IBB Position: Q3 2022 in Review

BTR Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 0.39% in Q3 2022, selling an estimated $4.35K and leaving 8,880 shares worth $1.04M. The position accounts for 0.16% of the portfolio, ranked #74.

BTR Capital Management first reported a position in IBB in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.37M in Q4 2014. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

  • BTR Capital Management held 8,880 shares of iShares Biotechnology ETF worth $1.04M as of Q3 2022.
  • BTR Capital Management sold 35 iShares Biotechnology ETF shares in Q3 2022, an estimated $4.35K.
  • iShares Biotechnology ETF made up 0.16% of BTR Capital Management's portfolio in Q3 2022, its #74 holding.
  • BTR Capital Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 38 quarters since.
  • BTR Capital Management's iShares Biotechnology ETF position peaked at $2.37M in Q4 2014.
  • 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.